Interestingly, a case of multiple endocrine neoplasia type 2A (MEN2A) with concurrent RNF213 and RET mutations demonstrated potential synergistic effects between genetic predisposition and catecholamine hypersecretion in intracranial stenosis development [109]. The gene discussed is RET; the disease is multiple endocrine neoplasia type 2A.